Newsroom | 12517 results

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) SurGenTec, LLC, a leader in innovative spine and orthopedic technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its ION-C™ navigation instruments for use with the ION-C™ posterior cervical facet fixation implant. The system is engineered for comp...

NEW YORK--(BUSINESS WIRE)--The Pershing Square Foundation (the “Foundation”) today announced $6 million in funding to support eight pioneering scientists advancing innovative ovarian cancer research across the United States. For more than a decade, the Foundation has advanced transformative cancer research through the Pershing Square Sohn Cancer Research Alliance (“PSSCRA”). Building on its longstanding commitment to cancer research and women’s health, the Foundation is now in the second year o...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that the Company will participate in the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting, taking place May 29 – June 2, 2026 in Cleveland, Ohio. At the meeting, NeuroPace will highlight the expanding role of responsive neuromodulation in epilepsy care, including long-term clinical out...

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the European Radiosurgery Center Munich (ERCM) has treated more than 1,000 patients with the ZAP-X® Gyroscopic Radiosurgery® platform. The milestone reflects ERCM’s continued leadership in stereotactic radiosurgery (SRS), a completely non-invasive and painless procedure used to treat many primary and metastatic brain tumors, as well as select disorders of...

TORONTO--(BUSINESS WIRE)--Cosm Medical has signed a licensing and collaboration agreement with two leading academic medical centers to develop personalized intravaginal devices...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies receives notice of allowance for Mexican patent on methods of predicting the likelihood of lung cancer using flow cytometry....

LOS ANGELES--(BUSINESS WIRE)--MedTech Innovator names 65 startups to 2026 cohort (top 4% of 1,835 applicants) and launches the MTI Index, a quantifiable benchmark for medtech....

AMSTERDAM--(BUSINESS WIRE)--Stryker (NYSE:SYK), ein weltweit führendes Unternehmen im Bereich Medizintechnik, gab heute die Markteinführung seines Pangea-Plattensystems in Europa bekannt, einer Plattensystem-Plattform zur Behandlung einer Vielzahl von Frakturmustern. Prof. Alex Trompeter, Design-Chirurg und orthopädischer Unfallchirurg, hat zusammen mit seinem Team am St. George’s University Hospital in London den ersten klinischen Eingriff in Europa durchgeführt. „Pangea wurde mit einem klaren...

AMSTERDAM--(BUSINESS WIRE)--Stryker (NYSE:SYK), een wereldleider in medische technologieën, kondigde vandaag de Europese lancering aan van zijn Pangea Plating System, een platform voor plaatjesosteosynthese voor de behandeling van uiteenlopende breukpatronen. Prof. Alex Trompeter, chirurg-ontwerper en orthopedisch traumachirurg, voltooide de eerste klinische case in Europa samen met zijn team aan de St. George's University Hospital in Londen. “Pangea werd ontwikkeld met een duidelijk doel voor...

RAYNHAM, Mass.--(BUSINESS WIRE)--DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced an exclusive distribution agreement1 with CGBIO, a biotechnology company specializing in regenerative medicine, for the development and commercialization of NOVOSIS, an advanced bone graft substitute containing growth factors, across its orthopaedic portfolio including spine, craniomaxillofacial (CMF), and trauma. NOVOSIS is a novel growth-factor bone graft substitute desig...